HopeStage
Back to all studies
CompletedNCT02371889

Topiramate and Genetic Factors in Heavy Drinking

About this titleRead the official source — NCT02371889
Medication studyAges 18–70United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
Philadelphia and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: December 18, 2014
Recruitment status
Completed
Enrollment listed in the registry
320
Sponsor
University of Pennsylvania
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT02371889
Official title
Show the full official title

A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Pennsylvania, a university.

Did this study involve medication?

Yes. The study involved medication, including Topiramate and Inactive Placebo.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies